Journal article
Ganciclovir-induced encephalopathy in a bone marrow transplant recipient
Bone marrow transplantation (Basingstoke), Vol.24(4), pp.421-423
1999
DOI: 10.1038/sj.bmt.1701933
PMID: 10467333
Abstract
Ganciclovir is widely used as prophylactic and pre-emptive therapy, as well as treatment, for CMV infection following BMT. We report a case treated with ganciclovir 5 days a week. Following escalation of the ganciclovir dose to a twice daily dose to treat CMV antigenaemia, he developed encephalopathy. His encephalopathy resolved with withdrawal of ganciclovir. Ganciclovir encephalopathy has been described in other groups of patients but has not been reported following BMT to date. With its widespread use this complication is likely to be seen more often.
Details
- Title: Subtitle
- Ganciclovir-induced encephalopathy in a bone marrow transplant recipient
- Creators
- A Sharathkumar - Children's Hospital at WestmeadP. J Shaw - Children's Hospital at Westmead
- Resource Type
- Journal article
- Publication Details
- Bone marrow transplantation (Basingstoke), Vol.24(4), pp.421-423
- DOI
- 10.1038/sj.bmt.1701933
- PMID
- 10467333
- NLM abbreviation
- Bone Marrow Transplant
- ISSN
- 0268-3369
- eISSN
- 1476-5365
- Publisher
- Nature Publishing Group
- Language
- English
- Date published
- 1999
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984353888602771
Metrics
9 Record Views